当前位置： SCI文献检索 > Molecular Cancer期刊下所有文献 > Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer.

Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer.

Abstract：

BACKGROUND:The disruption of normal gene regulation due to microRNA dysfunction is a common event in cancer pathogenesis. MicroRNA-27b is an example of an oncogenic miRNA, and it is frequently upregulated in breast cancer. MicroRNAs have been found to deregulate tumor metabolism, which typically manifests as heightened cellular glucose uptake in consort with increased flux through glycolysis, followed by the preferential conversion of glycolytic pyruvate into lactate (a phenomenon known as the Warburg Effect). Pyruvate Dehydrogenase, an enzyme complex linking glycolysis with downstream oxidative metabolism, represents a key location where regulation of metabolism occurs; PDHX is a key structural component of this complex and is essential for its function. METHODS:We sought to characterize the role of miR-27b in breast cancer by identifying novel transcripts under its control. We began by utilizing luciferase, RNA, and protein assays to establish PDHX as a novel target of miR-27b. We then tested whether miR-27b could alter metabolism using several metabolite assay kits and performed a seahorse analysis. We also examined how the altered metabolism might affect cell proliferation. Lastly, we confirmed the relevance of our findings in human breast tumor samples. RESULTS:Our data indicate that Pyruvate Dehydrogenase Protein X is a credible target of miR-27b in breast cancer. Mechanistically, by suppressing PDHX, miR-27b altered levels of pyruvate, lactate and citrate, as well as reducing mitochondrial oxidation and promoting extracellular acidification. These changes corresponded with an increased capacity for cell proliferation. In human breast tumor samples, PDHX expression was deficient, and low levels of PDHX were associated with reduced patient survival. CONCLUSIONS:MicroRNA-27b targets PDHX, resulting in an altered metabolic configuration that is better suited to fuel biosynthetic processes and cell proliferation, thereby promoting breast cancer progression.

journal_name

Mol Cancer

journal_title

Molecular cancer

authors

Eastlack SC,Dong S,Ivan C,Alahari SK

doi

10.1186/s12943-018-0851-8

subject

Has Abstract

pub_date

2018-07-16 00:00:00

pages

100

issue

issn

1476-4598

pii

10.1186/s12943-018-0851-8

journal_volume

pub_type

杂志文章

在线工具

Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer.